The BioInnovation Institute (BII) is an initiative from the Novo Nordisk Foundation which aims to support entrepreneurial researchers and early-stage life science start-ups with up to DKK 18 million in founder-friendly funding. CEO Jens Nielsen highlights some of the BII’s milestones and success stories since its formation and Denmark’s progress towards becoming a globally competitive life sciences innovation hub.
If a sufficiently large ecosystem is built here in Copenhagen, I believe big pharmaceutical companies will begin to settle in the area due to assets being purchased at a higher frequency and access to the ecosystem’s talent
